Evidence map›Paper›PMID 24298989›Full record

ArticleJournal of neurochemistry2014

Parkin reverses TDP-43-induced cell death and failure of amino acid homeostasis.

Michaeline Hebron, Wenqiang Chen, Matthew J Miessau, Irina Lonskaya, Charbel E-H Moussa

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurochemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer's Disease.International journal of molecular sciences · 2021
    Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Pathomechanisms of TDP-43 in neurodegeneration.Journal of neurochemistry · 2018
    Review
  17. Article
  18. TDP-43 in the spectrum of MND-FTLD pathologies.Molecular and cellular neurosciences · 2017
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Michaeline HebronDepartment of Neuroscience, Georgetown University Medical Center, Washington, District of Columbia, USA.
Wenqiang Chen
Matthew J Miessau
Irina Lonskaya
Charbel E-H Moussa
Georgetown University Medical Center · USGeorgetown University · US

Funding

Parkin protection in gene transfer animal models (KO-1 Award)K01AG030378 · NIA · GEORGETOWN UNIVERSITY · PI MOUSSA, CHARBEL · 2008 to 2012
$607k
NIA NIH HHS AG30378NIA NIH HHS K01 AG030378
6 · The paper itself

Abstract

The E3 ubiquitin ligase Parkin plays a central role in the pathogenesis of many neurodegenerative diseases. Parkin promotes specific ubiquitination and affects the localization of transactivation response DNA-binding protein 43 (TDP-43), which controls the translation of thousands of mRNAs. Here we tested the effects of lentiviral Parkin and TDP-43 expression on amino acid metabolism in the rat motor cortex using high frequency ¹³C NMR spectroscopy. TDP-43 expression increased glutamate levels, decreased the levels of other amino acids, including glutamine, aspartate, leucine and isoleucine, and impaired mitochondrial tricarboxylic acid cycle. TDP-43 induced lactate accumulation and altered the balance between excitatory (glutamate) and inhibitory (GABA) neurotransmitters. Parkin restored amino acid levels, neurotransmitter balance and tricarboxylic acid cycle metabolism, rescuing neurons from TDP-43-induced apoptotic death. Furthermore, TDP-43 expression led to an increase in 4E-BP levels, perhaps altering translational control and deregulating amino acid synthesis; while Parkin reversed the effects of TDP-43 on the 4E-BP signaling pathway. Taken together, these data suggest that Parkin may affect TDP-43 localization and mitigate its effects on 4E-BP signaling and loss of amino acid homeostasis.

Indexed as

Amino AcidsAnimalsBlotting, WesternCarrier ProteinsCaspase 3Cell DeathCitric Acid CycleFluorometrygamma-Aminobutyric AcidGenetic VectorsHomeostasisIntracellular Signaling Peptides and ProteinsLentivirusMagnetic Resonance SpectroscopyMaleMotor CortexAmino AcidsCarrier ProteinsCaspase 3Eif4ebp1 protein, ratgamma-Aminobutyric AcidIntracellular Signaling Peptides and ProteinsmTOR protein, ratNeurotransmitter Agentsparkin proteinPhosphoproteinsTOR Serine-Threonine KinasesUbiquitin-Protein Ligases13C NMRALSamino acidsParkinTDP-43

Identifiers

PMID24298989
PMCPMC3982293
OpenAlexW2026234649

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.